Cymabay Therapeutics

Home » Cymabay Therapeutics

Secondary

Cymabay Therapeutics

They are a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need.

Symbol

CBAY

Last Closing Price
$11.29

Shares
9,200,000

Effective Date
January 30, 2018

Underwriters
Leerink Partners, Evercore ISI

To view the prospectus for Cymabay Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253